101, are you saying Zweig's Signition Fund is taking a position in PPHM? Are they one of the new Top 10 that you keep referencing? Awful nice if that is the case.
BRATTON, D. L.; V. A. FADOK; D. A. RICHTER; J. M. KAILEY; L. A. GUTHRIE; P. M. HENSON.: 'Appearance of phosphatidylserine on apoptotic cells requires calcium- mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase.' J. BIOL. CHEM. vol. 272, 1997, pages 26159 - 26165
ZWAAL, R. F.; P. COMFURIUS; E. M. BEVERS.: 'Surface exposure of phosphatidylserine in pathological cells.' CELL MOL. LIFE SCI. vol. 62, 2005, pages 971 - 988
I sure am glad Dr. Thorpe et al patented Phosphatidlyserine Targeting!
Do we bounce off that 200 DMA?!?!?
I expected a deep V with no AM news.....
Is anyone (in particular) going to show up and start saying "the 200 DMA stopped that downturn in its' tracks" if it continually holds? NAHHHH.